NO167187C - Fremgangsmaate til fremstilling av et legemiddel. - Google Patents
Fremgangsmaate til fremstilling av et legemiddel.Info
- Publication number
- NO167187C NO167187C NO842978A NO842978A NO167187C NO 167187 C NO167187 C NO 167187C NO 842978 A NO842978 A NO 842978A NO 842978 A NO842978 A NO 842978A NO 167187 C NO167187 C NO 167187C
- Authority
- NO
- Norway
- Prior art keywords
- denotes
- phe
- formula
- physiologically acceptable
- medicine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
- C07K14/625—Extraction from natural sources
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
- Prostheses (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19833326473 DE3326473A1 (de) | 1983-07-22 | 1983-07-22 | Pharmazeutisches mittel zur behandlung des diabetes mellitus |
Publications (3)
Publication Number | Publication Date |
---|---|
NO842978L NO842978L (no) | 1985-01-23 |
NO167187B NO167187B (no) | 1991-07-08 |
NO167187C true NO167187C (no) | 1991-10-16 |
Family
ID=6204661
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO842978A NO167187C (no) | 1983-07-22 | 1984-07-20 | Fremgangsmaate til fremstilling av et legemiddel. |
Country Status (19)
Country | Link |
---|---|
US (1) | US4608364A (nl) |
EP (1) | EP0132769B1 (nl) |
JP (1) | JPS6042334A (nl) |
AT (1) | ATE31625T1 (nl) |
AU (1) | AU564648B2 (nl) |
CA (1) | CA1236012A (nl) |
DE (2) | DE3326473A1 (nl) |
DK (1) | DK172456B1 (nl) |
ES (1) | ES534488A0 (nl) |
FI (1) | FI79786C (nl) |
GR (1) | GR81550B (nl) |
HU (1) | HUT34889A (nl) |
IE (1) | IE57690B1 (nl) |
IL (1) | IL72468A (nl) |
NO (1) | NO167187C (nl) |
NZ (1) | NZ208960A (nl) |
PH (1) | PH21328A (nl) |
PT (1) | PT78941A (nl) |
ZA (1) | ZA845621B (nl) |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5008241A (en) * | 1985-03-12 | 1991-04-16 | Novo Nordisk A/S | Novel insulin peptides |
US4946828A (en) * | 1985-03-12 | 1990-08-07 | Novo Nordisk A/S | Novel insulin peptides |
AU612141B2 (en) * | 1987-02-25 | 1991-07-04 | Novo Nordisk A/S | Novel insulin derivatives |
US4764592A (en) * | 1987-04-23 | 1988-08-16 | Eli Lilly And Company | Crystalline human proinsulin and process for its production |
DE3717370A1 (de) * | 1987-05-22 | 1988-12-01 | Hoechst Ag | Mischkristalle aus insulin und insulinderivaten, verfahren zur herstellung dieser mischkristalle, diese mischkristalle enthaltende pharmazeutische mittel und ihre verwendung zur behandlung von diabetes mellitus |
US4789660A (en) * | 1987-09-10 | 1988-12-06 | American Home Products Corporation | Insulin administration using methyl and propyl paraben |
EP0347781B1 (de) * | 1988-06-23 | 1994-02-16 | Hoechst Aktiengesellschaft | Mini-Proinsulin, seine Herstellung und Verwendung |
US6875589B1 (en) | 1988-06-23 | 2005-04-05 | Hoechst Aktiengesellschaft | Mini-proinsulin, its preparation and use |
DE3827533A1 (de) * | 1988-08-13 | 1990-02-15 | Hoechst Ag | Pharmazeutische zubereitung zur behandlung des diabetes mellitus |
DE3837825A1 (de) * | 1988-11-08 | 1990-05-10 | Hoechst Ag | Neue insulinderivate, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung |
DK134189D0 (da) * | 1989-03-20 | 1989-03-20 | Nordisk Gentofte | Insulinforbindelser |
DE3936876A1 (de) * | 1989-11-06 | 1991-05-23 | Hoechst Ag | Neue insulinderivate, verfahren zu deren herstellung, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung |
IL99699A (en) * | 1990-10-10 | 2002-04-21 | Autoimmune Inc | Drug with the option of oral, intra-intestinal, or inhaled dosing for suppression of autoimmune response associated with type I diabetes |
WO1992010284A2 (en) | 1990-12-07 | 1992-06-25 | Cnc Development, Inc. | Catalytic chemical reactor |
YU66892A (sh) * | 1991-08-20 | 1995-10-24 | Hoechst Ag. | Fosfoinositolglikan - peptid sa delovanjem kao insulin |
CZ342492A3 (en) * | 1991-11-26 | 1993-06-16 | Lilly Co Eli | Derivatives of tri-arginine insulin, process of their preparation and a pharmaceutical composition in which said derivatives are comprised |
DE59209745D1 (de) * | 1991-11-29 | 1999-10-21 | Hoechst Ag | Peptide mit insulinartiger Wirkung |
CA2087087C (en) * | 1992-01-22 | 2000-07-18 | Burton H. Sage, Jr. | Molecules for iontophoretic delivery |
DK72793D0 (da) * | 1993-06-21 | 1993-06-21 | Novo Nordisk As | Nyt produkt |
US5461031A (en) * | 1994-06-16 | 1995-10-24 | Eli Lilly And Company | Monomeric insulin analog formulations |
US5547929A (en) * | 1994-09-12 | 1996-08-20 | Eli Lilly And Company | Insulin analog formulations |
US6451970B1 (en) | 1996-02-21 | 2002-09-17 | Novo Nordisk A/S | Peptide derivatives |
SE520392C2 (sv) | 1996-09-27 | 2003-07-01 | Creative Peptides Sweden Ab C | Specifika peptider för behandling av diabetes mellitus |
DE19649350A1 (de) * | 1996-11-28 | 1998-06-04 | Hoechst Ag | Inositolglykane mit insulinartiger Wirkung |
US6444641B1 (en) | 1997-10-24 | 2002-09-03 | Eli Lilly Company | Fatty acid-acylated insulin analogs |
BR9813111A (pt) | 1997-10-24 | 2000-08-15 | Lilly Co Eli | Composições de insulina insolúveis |
CO4970787A1 (es) * | 1997-12-23 | 2000-11-07 | Lilly Co Eli | Composiciones insolubles de insulina y derivados de insulina que controlan la glucosa sanguinea |
ES2208305T3 (es) | 1999-04-08 | 2004-06-16 | Genentech, Inc. | Composicion basada en polipeptidos de carga opuesta.. |
US6852694B2 (en) | 2001-02-21 | 2005-02-08 | Medtronic Minimed, Inc. | Stabilized insulin formulations |
DE10114178A1 (de) | 2001-03-23 | 2002-10-10 | Aventis Pharma Gmbh | Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität |
DE10227232A1 (de) * | 2002-06-18 | 2004-01-15 | Aventis Pharma Deutschland Gmbh | Saure Insulinzubereitungen mit verbesserter Stabilität |
GB0323979D0 (en) | 2003-10-13 | 2003-11-19 | Creative Peptides Sweden Ab | Therapeutic applications for c-peptide |
GB0601950D0 (en) * | 2006-01-31 | 2006-03-15 | Creative Peptides Sweden Ab | Compositions and methods of treating diabetes |
DE102006031962A1 (de) | 2006-07-11 | 2008-01-17 | Sanofi-Aventis Deutschland Gmbh | Amidiertes Insulin Glargin |
DE102006031955A1 (de) | 2006-07-11 | 2008-01-17 | Sanofi-Aventis Deutschland Gmbh | Verfahren zur Herstellung von Insulinanaloga mit dibasischem B-Kettenende |
EP2341942A1 (en) | 2008-09-19 | 2011-07-13 | Nektar Therapeutics | Polymer conjugates of therapeutic peptides |
PT3228320T (pt) | 2008-10-17 | 2020-03-26 | Sanofi Aventis Deutschland | Combinação de uma insulina e de um agonista do glp-1 |
US8410049B2 (en) * | 2009-10-28 | 2013-04-02 | Cebix | Methods and kits for preventing hypoglycemia |
RU2537239C2 (ru) | 2009-11-13 | 2014-12-27 | Санофи-Авентис Дойчланд Гмбх | Фармацевтическая композиция, включающая агонист glp-1, инсулин и метионин |
PT2498801T (pt) | 2009-11-13 | 2018-05-02 | Sanofi Aventis Deutschland | Composição farmacêutica compreendendo despro36exendin-4(1-39)-lys6-nh2 e metionina |
RU2546520C2 (ru) | 2010-08-30 | 2015-04-10 | Санофи-Авентис Дойчланд Гмбх | Применение ave0010 для производства лекарственного средства для лечения сахарного диабета 2 типа |
US9821032B2 (en) | 2011-05-13 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin |
ES2550357T3 (es) | 2011-08-29 | 2015-11-06 | Sanofi-Aventis Deutschland Gmbh | Combinación farmacéutica para su uso en el control glucémico en pacientes de diabetes de tipo 2 |
TWI559929B (en) | 2011-09-01 | 2016-12-01 | Sanofi Aventis Deutschland | Pharmaceutical composition for use in the treatment of a neurodegenerative disease |
HUE062573T2 (hu) | 2014-12-12 | 2023-11-28 | Sanofi Aventis Deutschland | Glargin inzulin/lixiszenatid rögzített arányú készítmény |
TWI748945B (zh) | 2015-03-13 | 2021-12-11 | 德商賽諾菲阿凡提斯德意志有限公司 | 第2型糖尿病病患治療 |
TW201705975A (zh) | 2015-03-18 | 2017-02-16 | 賽諾菲阿凡提斯德意志有限公司 | 第2型糖尿病病患之治療 |
EP3463413A4 (en) * | 2016-05-25 | 2020-03-04 | Merck Sharp & Dohme Corp. | PARTIAL INSULIN RECEPTOR AGONISTS |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1176159A (en) * | 1981-08-27 | 1984-10-16 | Ronald E. Chance | Pharmaceutical formulations comprising human insulin, human c-peptide, and human proinsulin |
DOP1982004086A (es) * | 1981-08-27 | 1988-03-22 | Lilly Co Eli | Formula farmaceutica que comprende insulina humana y proinsulina humana |
CH650679A5 (de) * | 1981-08-27 | 1985-08-15 | Lilly Co Eli | Gegen diabetes mellitus wirksames pharmazeutisches mittel. |
CH650677A5 (de) * | 1981-08-27 | 1985-08-15 | Lilly Co Eli | Gegen diabetes mellitus wirksames pharmazeutisches mittel. |
NL8201650A (nl) * | 1982-04-21 | 1983-11-16 | Akzo Nv | Semisynthetische bereiding van humane insuline. |
-
1983
- 1983-07-22 DE DE19833326473 patent/DE3326473A1/de not_active Withdrawn
-
1984
- 1984-07-16 HU HU842765A patent/HUT34889A/hu unknown
- 1984-07-18 EP EP84108441A patent/EP0132769B1/de not_active Expired
- 1984-07-18 AT AT84108441T patent/ATE31625T1/de not_active IP Right Cessation
- 1984-07-18 DE DE8484108441T patent/DE3468323D1/de not_active Expired
- 1984-07-18 GR GR75341A patent/GR81550B/el unknown
- 1984-07-19 FI FI842915A patent/FI79786C/fi not_active IP Right Cessation
- 1984-07-19 PT PT78941A patent/PT78941A/pt not_active IP Right Cessation
- 1984-07-20 DK DK198403583A patent/DK172456B1/da not_active IP Right Cessation
- 1984-07-20 IL IL72468A patent/IL72468A/xx not_active IP Right Cessation
- 1984-07-20 NO NO842978A patent/NO167187C/no unknown
- 1984-07-20 ZA ZA845621A patent/ZA845621B/xx unknown
- 1984-07-20 AU AU30917/84A patent/AU564648B2/en not_active Ceased
- 1984-07-20 CA CA000459385A patent/CA1236012A/en not_active Expired
- 1984-07-20 IE IE1890/84A patent/IE57690B1/en not_active IP Right Cessation
- 1984-07-20 PH PH31011A patent/PH21328A/en unknown
- 1984-07-20 JP JP59149785A patent/JPS6042334A/ja active Granted
- 1984-07-20 US US06/632,859 patent/US4608364A/en not_active Expired - Lifetime
- 1984-07-20 NZ NZ208960A patent/NZ208960A/xx unknown
- 1984-07-20 ES ES534488A patent/ES534488A0/es active Granted
Also Published As
Publication number | Publication date |
---|---|
FI79786C (fi) | 1990-03-12 |
DK358384A (da) | 1985-01-23 |
JPS6042334A (ja) | 1985-03-06 |
AU3091784A (en) | 1985-01-24 |
EP0132769B1 (de) | 1988-01-07 |
PH21328A (en) | 1987-10-13 |
IE841890L (en) | 1985-01-22 |
NO842978L (no) | 1985-01-23 |
ATE31625T1 (de) | 1988-01-15 |
JPH0469128B2 (nl) | 1992-11-05 |
US4608364A (en) | 1986-08-26 |
IE57690B1 (en) | 1993-03-10 |
AU564648B2 (en) | 1987-08-20 |
ES8504456A1 (es) | 1985-05-01 |
FI842915A (fi) | 1985-01-23 |
GR81550B (nl) | 1984-12-11 |
ZA845621B (en) | 1985-02-27 |
FI79786B (fi) | 1989-11-30 |
IL72468A0 (en) | 1984-11-30 |
NO167187B (no) | 1991-07-08 |
HUT34889A (en) | 1985-05-28 |
CA1236012A (en) | 1988-05-03 |
DK358384D0 (da) | 1984-07-20 |
DE3326473A1 (de) | 1985-01-31 |
DE3468323D1 (en) | 1988-02-11 |
PT78941A (de) | 1984-08-01 |
ES534488A0 (es) | 1985-05-01 |
EP0132769A1 (de) | 1985-02-13 |
IL72468A (en) | 1989-08-15 |
NZ208960A (en) | 1989-02-24 |
DK172456B1 (da) | 1998-08-24 |
FI842915A0 (fi) | 1984-07-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO167187C (no) | Fremgangsmaate til fremstilling av et legemiddel. | |
ES8505646A1 (es) | Procedimiento para la preparacion de un derivado de insulina | |
SE8102194L (sv) | Terapeutiskt aktiv organisk forening och farmaceutisk beredning innehallande denna | |
DE68929217T2 (de) | Insulinotropes hormon | |
DK393288D0 (da) | Praeparat til saarheling og knogleregenerering | |
DE69132688T2 (de) | Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin | |
GR1001503B (el) | Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών. | |
FI893783A0 (fi) | Menetelmä diabetes mellituksen hoitoon tarkoitetun farmaseuttisen valmisteen valmistamiseksi | |
IT8248200A0 (it) | Preparato farmaceutico per la cura del diabete mellitus | |
DE3566545D1 (en) | 2-substituted-1,3-propylidenediphosphonate derivatives, the process for their preparation and pharmaceutical compositions containing them | |
KR910000158A (ko) | 의약용 화합물 및 그것의 사용방법 | |
DK296389D0 (da) | Farmaceutiske forbindelser | |
DK204686A (da) | Quinolylglycinamidderivater og fremgangsmaade til fremstilling deraf | |
SE8204873D0 (sv) | Farmaceutiska preparat, innefattande humant insulin och human c-peptid | |
ES455691A1 (es) | Procedimiento para la produccion de derivados de piperacina. | |
JPS5344616A (en) | Injections | |
ATE82850T1 (de) | Verwendung von 2-pyrimidinyl-1-piperazinderivaten. | |
DE3667472D1 (de) | Analoge von hypokalzemischen polypeptiden, welche den kalziumgehalt des koerpers schonen, deren herstellung, deren verwendung als arznei und diese enthaltende zusammensetzungen. | |
GB2021581A (en) | Stabilisation of PGl2 derivatives | |
GR3004272T3 (nl) | ||
FI953927A (fi) | Menetelmä lääkeaineina käyttökelpoisten milbemysiinin johdannaisten valmistamiseksi |